Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
DuoPlavin
Generic name / active ingredient
clopidogrel and acetylsalicylic acid film-coated tablets
Dosage-form class
DuoPlavin film-coated tablets combine clopidogrel 75 mg with aspirin 75 mg or 100 mg in one tablet. The two figures belong to two active ingredients, not one 150 mg or 175 mg medicine; this page does not infer splitting permission from the oval shape.
Route
Oral (fixed two-ingredient product-identity field)
Record reviewed
2026-09-06

Copy from the pack in hand

Source-linked reading points

  • This tablet already contains aspirin and clopidogrel. Review prescriptions, OTC pain/cold products, supplements and actual packs together. Another aspirin, PLAVIX/clopidogrel, antiplatelet, oral anticoagulant, heparin, thrombolytic or NSAID may increase bleeding risk; self-separating times does not remove that risk.
  • Vomiting blood or coffee-ground material, black or bloody stool, persistent or uncontrolled bleeding, sudden severe headache with awareness/speech/limb change, fainting, breathing difficulty or severe allergy requires prompt local medical care; severe acute features require emergency help.
  • Tell physicians and dentists about DuoPlavin before surgery, dental work or another invasive procedure. Do not stop it from a web page; the responsible team must decide timing from both thrombotic and bleeding risks.
  • Severe kidney or liver problems, active bleeding or peptic ulcer, aspirin/NSAID allergy or related asthma, pregnancy, prior falls/bleeding, or co-listing of an SSRI, omeprazole/esomeprazole, rifampicin or similar medicines requires priority professional review of the current label.

Reviewed presentation examples — compare every field

  • Clopidogrel 75 mg plus aspirin 75 mg per tablet; 14-tablet blister carton; not one 150 mg medicineEU/1/10/619/001
  • Clopidogrel 75 mg plus aspirin 75 mg per tablet; 28-tablet blister carton; not one 150 mg medicineEU/1/10/619/002
  • Clopidogrel 75 mg plus aspirin 75 mg per tablet; 30 × 1-tablet unit-dose blister carton; not one 150 mg medicineEU/1/10/619/003
  • Clopidogrel 75 mg plus aspirin 75 mg per tablet; 50 × 1-tablet unit-dose blister carton; not one 150 mg medicineEU/1/10/619/004
  • Clopidogrel 75 mg plus aspirin 75 mg per tablet; 84-tablet blister carton; not one 150 mg medicineEU/1/10/619/005
  • Clopidogrel 75 mg plus aspirin 75 mg per tablet; 90 × 1-tablet unit-dose blister carton; not one 150 mg medicineEU/1/10/619/006
  • Clopidogrel 75 mg plus aspirin 75 mg per tablet; 100 × 1-tablet unit-dose blister carton; not one 150 mg medicineEU/1/10/619/007
  • Clopidogrel 75 mg plus aspirin 75 mg per tablet; 30-tablet blister carton; not one 150 mg medicineEU/1/10/619/015

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-09-06
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image